AMY L. RONNEBERG

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Paul Lytle, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by AMY L. RONNEBERG:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACTUATE THERAPEUTICS, INC. Director Non-Qualified Stock Options 30,000 12 Aug 2024 Direct
Magenta Therapeutics, Inc. Director Stock Option (Right to Buy) 20,000 28 Jun 2022 Direct
ACTUATE THERAPEUTICS, INC. Director Stock Options 15,000 22 May 2025 Direct

Insider Reports Filed by AMY L. RONNEBERG

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACTU ACTUATE THERAPEUTICS, INC. 22 May 2025 1 $0 4 Director 23 May 2025, 16:05
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 1 $0 4 Director 14 Aug 2024, 19:26
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 0 $0 3 Director 14 Aug 2024, 19:23
DNTH Magenta Therapeutics, Inc. 28 Jun 2022 1 $0 4 Director 30 Jun 2022, 18:34
DNTH Magenta Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 18:34